Microcurrent Treatment for Chronic Debilitating Pain
CompletedNot applicableNCT04011176
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
To compare the efficacy of standard pain treatment and placebo (a microcurrent faux treatment) as opposed to standard pain treatment and microcurrent therapy in any primary care patients over a three month period.
Study details
- Official title
- Microcurrent Treatment for Chronic Debilitating Pain
- Conditions
- Interventions
- Procedure: Standard treatment + placebo
- Procedure: Standard treatment + Microcurrent Therapy
- Sponsor
- Paul Crawford
- Organization
- Mike O'Callaghan Military Hospital
- Start date
- 2019-12-09
- Primary completion
- 2022-06-01
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
\*\*Patients must be able to get care at Nellis Air Force Base (a military installation) in order to participate in this study\*\* Inclusion Criteria: * Male and female Active Duty members and DoD beneficiaries * Age 18 years or older * Chronic debilitating pain * PROMIS-57 T score is 60 or above Exclusion Criteria: * Pregnant * Implanted pacemaker * Spinal cord stimulator * Illicit drug use including marijuana use * Epilepsy or a history of seizures * Other implanted device (e.g., insulin pump, opioid pump, or defibrillator) * Chronic debilitating pain referred or recruited as measured by PROMIS-57 T score is below 60
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04011176